73 related articles for article (PubMed ID: 9127204)
1. Studies on penam sulfones. II. Synthesis and beta-lactamase inhibitory activity of 2 beta-carboxamide penicillanic acid sulfones.
Reddy NA; Setti EL; Phillips OA; Czajkowski DP; Atwal H; Atchison K; Micetich RG; Maiti SN; Kunugita C; Hyodo A
J Antibiot (Tokyo); 1997 Mar; 50(3):276-8. PubMed ID: 9127204
[No Abstract] [Full Text] [Related]
2. Synthesis and biological evaluation of penam sulfones as inhibitors of beta-lactamases.
Phillips OA; Reddy AV; Setti EL; Spevak P; Czajkowski DP; Atwal H; Salama S; Micetich RG; Maiti SN
Bioorg Med Chem; 2005 Apr; 13(8):2847-58. PubMed ID: 15781395
[TBL] [Abstract][Full Text] [Related]
3. Studies on penam sulfones. I. Synthesis and beta-lactamase inhibitory activity of 2 beta-alkoxycarbonyl penicillanic acid sulfones.
Setti EL; Reddy NA; Phillips OA; Czajkowski DP; Atchison K; Atwal H; Micetich RG; Maiti SN; Kunugita C; Hyodo A
J Antibiot (Tokyo); 1996 Sep; 49(9):944-6. PubMed ID: 8931732
[No Abstract] [Full Text] [Related]
4. Design, synthesis, and evaluation of 2 beta-alkenyl penam sulfone acids as inhibitors of beta-lactamases.
Richter HG; Angehrn P; Hubschwerlen C; Kania M; Page MG; Specklin JL; Winkler FK
J Med Chem; 1996 Sep; 39(19):3712-22. PubMed ID: 8809160
[TBL] [Abstract][Full Text] [Related]
5. Allyl and propargyl substituted penam sulfones as versatile intermediates toward the syntheses of new beta-lactamase inhibitors.
Sandanayaka VP; Feigelson GB; Prashad AS; Yang Y; Petersen PJ
Bioorg Med Chem Lett; 2001 Apr; 11(8):997-1000. PubMed ID: 11327608
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design of beta-lactamase inhibitors. 1. Synthesis and evaluation of bridged monobactams.
Heinze-Krauss I; Angehrn P; Charnas RL; Gubernator K; Gutknecht EM; Hubschwerlen C; Kania M; Oefner C; Page MG; Sogabe S; Specklin JL; Winkler F
J Med Chem; 1998 Oct; 41(21):3961-71. PubMed ID: 9767633
[TBL] [Abstract][Full Text] [Related]
7. Studies on penam sulfones. II. Synthesis and beta-lactamase inhibitory activity of 2 beta-carboxamide penicillanic acid sulfones.
Reddy NA; Setti EL; Phillips OA; Czajkowski DP; Atwal H; Atchison K; Micetich RG; Maiti SN; Kunugita C; Hyodo A
J Antibiot (Tokyo); 1997 Mar; 50(3):276-8. PubMed ID: 9439704
[No Abstract] [Full Text] [Related]
8. Synthesis and beta-lactamase inhibitory activity of thiazolyl penam sulfones.
Chen YL; Hedberg K; Barrett JF; Retsema JA
J Antibiot (Tokyo); 1988 Jan; 41(1):134-8. PubMed ID: 3257960
[No Abstract] [Full Text] [Related]
9. 6-(1-Hydroxyalkyl))penam sulfone derivatives as inhibitors of class A and class C beta-lactamases II.
Bitha P; Li Z; Francisco GD; Yang Y; Petersen PJ; Lenoy E; Lin YI
Bioorg Med Chem Lett; 1999 Apr; 9(7):997-1002. PubMed ID: 10230627
[TBL] [Abstract][Full Text] [Related]
10. 6-(1-Hydroxyalkyl)penam sulfone derivatives as inhibitors of class A and class C beta-lactamases I.
Bitha P; Li Z; Francisco GD; Rasmussen BA; Lin YI
Bioorg Med Chem Lett; 1999 Apr; 9(7):991-6. PubMed ID: 10230626
[TBL] [Abstract][Full Text] [Related]
11. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
Weston GS; Blázquez J; Baquero F; Shoichet BK
J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of 3-(carboxymethylidene)- and 3-(carboxymethyl)penicillinates as inhibitors of beta-lactamase.
Buynak JD; Ghadachanda VR; Vogeti L; Zhang H; Chen H
J Org Chem; 2005 May; 70(11):4510-3. PubMed ID: 15903334
[TBL] [Abstract][Full Text] [Related]
13. [Beta-lactamase inhibitors. I. Synthesis and biological properties of penicillanic acid derivatives].
Mikołajczyk J; Kotulowa W; Kazimierczak J; Sikora A; Rogowska W; Cieślak J
Acta Pol Pharm; 1980; 37(6):637-41. PubMed ID: 6270960
[No Abstract] [Full Text] [Related]
14. Exploring the effectiveness of tazobactam against ceftazidime resistant Escherichia coli: insights from the comparison between susceptibility testing and beta-lactamase inhibition.
Bethel CR; Hujer AM; Helfand MS; Bonomo RA
FEMS Microbiol Lett; 2004 May; 234(1):99-103. PubMed ID: 15109726
[TBL] [Abstract][Full Text] [Related]
15. Nanomolar inhibitors of AmpC beta-lactamase.
Morandi F; Caselli E; Morandi S; Focia PJ; Blázquez J; Shoichet BK; Prati F
J Am Chem Soc; 2003 Jan; 125(3):685-95. PubMed ID: 12526668
[TBL] [Abstract][Full Text] [Related]
16. Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase.
Buzzoni V; Blazquez J; Ferrari S; Calò S; Venturelli A; Costi MP
Bioorg Med Chem Lett; 2004 Aug; 14(15):3979-83. PubMed ID: 15225711
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of 2 beta-oxyimino and alkenylpenicillanic acid sulfone derivatives as beta-lactamase inhibitors.
Cho YS; Ha YJ; Kwon JS; Pae AN; Choi KI; Koh HY; Chang MH; Yoon CM; Lee GS
Arch Pharm (Weinheim); 1999 Jan; 332(1):7-12. PubMed ID: 10073138
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of beta-lactamase inhibitors. 2. Synthesis and evaluation of bridged sulfactams and oxamazins.
Hubschwerlen C; Angehrn P; Gubernator K; Page MG; Specklin JL
J Med Chem; 1998 Oct; 41(21):3972-5. PubMed ID: 9767634
[TBL] [Abstract][Full Text] [Related]
19. beta-Keto sulfones as inhibitors of 11beta-hydroxysteroid dehydrogenase type I and the mechanism of action.
Xiang J; Ipek M; Suri V; Tam M; Xing Y; Huang N; Zhang Y; Tobin J; Mansour TS; McKew J
Bioorg Med Chem; 2007 Jul; 15(13):4396-405. PubMed ID: 17490884
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of sulfonamidooxazoles and beta-keto sulfones: selective inhibitors of 11beta-hydroxysteroid dehydrogenase type I.
Xiang J; Ipek M; Suri V; Massefski W; Pan N; Ge Y; Tam M; Xing Y; Tobin JF; Xu X; Tam S
Bioorg Med Chem Lett; 2005 Jun; 15(11):2865-9. PubMed ID: 15911270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
